Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2

Am J Dermatopathol. 2023 Jan 1;45(1):47-50. doi: 10.1097/DAD.0000000000002286. Epub 2022 Nov 2.

Abstract

Deficiency of adenosine deaminase type 2 (DADA2) is an autosomal recessive monogenic autoinflammatory syndrome that is classically characterised by polyarteritis nodosa, systemic vasculitis and stroke. The spectrum of disease manifestations has broadened to encompass a range of cutaneous, vascular and haematological manifestations. We report a novel association in two sisters with heterozygous p.R169G/p.M309l mutations in ADA2 with low serum ADA2 activity who both presented similarly with clinical and histological features consistent with histiocytoid Sweet syndrome.

MeSH terms

  • Adenosine Deaminase* / deficiency
  • Adenosine Deaminase* / genetics
  • Humans
  • Intercellular Signaling Peptides and Proteins* / deficiency
  • Intercellular Signaling Peptides and Proteins* / genetics
  • Mutation
  • Polyarteritis Nodosa / genetics
  • Sweet Syndrome* / diagnosis
  • Sweet Syndrome* / genetics

Substances

  • Adenosine Deaminase
  • Intercellular Signaling Peptides and Proteins
  • ADA2 protein, human